NEW YORK – Swedish startup CubaseBio said on Tuesday that it has raised €5.9 million ($7.0 million) in funding to develop its 3D spatial transcriptomics technology for drug discovery and disease research.

纽约——瑞典初创公司CubaseBio周二表示，已筹集了590万欧元（700万美元）的资金，用于开发其用于药物发现和疾病研究的3D空间转录组学技术。

The funding includes a €2 million non-dilutive grant from the European Innovation Council (EIC) Transition Program and €3.9 million in private financing that was led by Voima Ventures and Nordic Science Investments (NSI). Other contributors included Illumina Ventures, Almi invest, Life Science Invest, and several undisclosed private investors..

这笔资金包括来自欧洲创新委员会（EIC）过渡计划的200万欧元非稀释性拨款，以及由Voima Ventures和北欧科学投资（NSI）领投的390万欧元私人融资。其他参与者包括Illumina Ventures、Almi Invest、Life Science Invest，以及若干未披露身份的私人投资者。

Founded in 2024, Stockholm-based CubaseBio said its 3D spatial analysis approach enables the analysis of transcriptomes in complex three-dimensional samples such as organoids and intact organisms. It builds on

2024年成立的斯德哥尔摩CubaseBio公司表示，其3D空间分析方法能够对类器官和完整生物体等复杂的三维样本中的转录组进行分析。该方法基于

DNA microscopy

DNA显微技术

technology developed by its scientific advisors and cofounders Joshua Weinstein, an assistant professor of molecular engineering at the University of Chicago, and Björn Högberg, a professor of medical biochemistry and biophysics at the Karolinska Institute.

由其科学顾问兼联合创始人、芝加哥大学分子工程助理教授约书亚·温斯坦和卡罗林斯卡学院医学生物化学与生物物理学教授比约恩·霍格伯格开发的技术。

Other CubaseBio cofounders include Malte Kuhnemund, Xiaoyan Qian, Toon Verheyen, and Paulius Mielinis. Kuhnemund and Qian previously established

其他CubaseBio联合创始人包括马尔特·库内蒙德、钱晓燕、图恩·维尔海恩和保柳斯·米埃利尼斯。库内蒙德和钱晓燕此前曾建立

Cartana

卡塔纳

, a Scilifelab spinout that was developing

，一家正在开发的Scilifelab分拆公司

in situ

原位

RNA sequencing technology. Cartana was

RNA测序技术。Cartana是一家

acquired by 10x Genomics

被10x Genomics收购

in 2020 to form the foundation of the firm's Xenium platform, according to CubaseBio.

据CubaseBio称，该平台于2020年构建了公司Xenium平台的基础。

'Biology is three-dimensional. We want to enable measuring it in that way,' Kuhnemund, who serves as CubaseBio's CEO, said in a statement.

“生物学是三维的。我们希望实现以这种方式对其进行测量，”库纳曼德在一份声明中表示，他担任CubaseBio的首席执行官。